Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marignier

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Neurology|March 10, 2012
Neuromyelitis optica and pregnancyB Bourre, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2009
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West IndiesJ A Cabrera-Gómez, M Bonnan, A González-Quevedo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Efficacy of rituximab in refractory neuromyelitis opticaN Collongues, D Brassat, E Maillart, et al.
Lupus|August 14, 2014
Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patientsJ Saison, N Costedoat-Chalumeau, D Maucort-Boulch, et al.
European Journal of Neurology|September 19, 2019
Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patientsN Shor, J Aboab, E Maillart, et al.
Clinical and Experimental Immunology|October 17, 2015
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phaseP O Barros, T Cassano, J Hygino, et al.
Neurology|September 22, 2010
Long-term follow-up of neuromyelitis optica with a pediatric onsetN Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique|October 13, 2020
MRI characteristics of MOG-Ab associated disease in adults: An updateN Shor, R Deschamps, A Cobo Calvo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2013
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetN Collongues, R Marignier, A Jacob, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2017
Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patientsL Le Berre, J Rousse, P-A Gourraud, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Neurology|March 10, 2012
Neuromyelitis optica and pregnancyB Bourre, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2009
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West IndiesJ A Cabrera-Gómez, M Bonnan, A González-Quevedo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Efficacy of rituximab in refractory neuromyelitis opticaN Collongues, D Brassat, E Maillart, et al.
Lupus|August 14, 2014
Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patientsJ Saison, N Costedoat-Chalumeau, D Maucort-Boulch, et al.
European Journal of Neurology|September 19, 2019
Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patientsN Shor, J Aboab, E Maillart, et al.
Clinical and Experimental Immunology|October 17, 2015
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phaseP O Barros, T Cassano, J Hygino, et al.
Neurology|September 22, 2010
Long-term follow-up of neuromyelitis optica with a pediatric onsetN Collongues, R Marignier, H Zéphir, et al.
Revue Neurologique|October 13, 2020
MRI characteristics of MOG-Ab associated disease in adults: An updateN Shor, R Deschamps, A Cobo Calvo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2013
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetN Collongues, R Marignier, A Jacob, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2017
Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patientsL Le Berre, J Rousse, P-A Gourraud, et al.
Pageof 5